why choose us

First received: January 21, 2025

Clinical Trial: Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Post Traumatic Stress Disorder PTSD

Study Type: INTERVENTIONAL


Official Title: Combining Esketamine and Prolonged Exposure for PTSD: A Proof-of-Concept Clinical Trial

Brief Summary: This study is being done to see if Prolonged Exposure (PE), a well-researched, very effective individual (one-to-one) behavioral therapy designed to help people to directly deal with traumatic events they have suffered in the past, can be combined with intranasal esketamine (ketamine) for the treatment of posttraumatic stress disorder (PTSD) to enhance treatment benefits.Ketamine nasal spray is a drug approved by the U.S. Food & Drug Administration (FDA) for treatment resistant depression.Combined with PE,…

Read more